Artelo Biosciences receives Nasdaq minimum bid price deficiency notice; 180-day cure period until Oct 20, 2025

ARTELO BIOSCIENCES, INC.

Received Nasdaq notice on April 23, 2025 for non-compliance with $1.00 minimum bid price requirement.
Must regain compliance by Oct 20, 2025; closing bid price must meet or exceed $1.00 for 10 consecutive business days.
Possible second 180-day extension if other listing standards met; company may implement a reverse stock split.
No immediate effect on listing; company intends to monitor bid price and evaluate available options.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.